Financial

New Financing to Complete Pivotal Artificial Disc Studies

Simplify Medical has raised $21M which it says will see its two ongoing studies to completion

ZCube, Research Venture of Italian pharma company Zambon, launches second edition of Open Accelerator for life sciences startups

ZipLine Medical brings in $12M from equity fund HighCape Partners

It seems that making spine surgery safer is quite a lucrative business

Additional funding from existing investors supports regulatory progress in USA and Japan

Continued strong growth in 2016. Company now has more than 150 patents and trademarks worldwide

MD Start II follows its successful predecessor by offering incubation and management for start-ups

FMX314 received both CE Mark Approval and U.S. FDA 510(k) clearance last quarter

Israel’s Office of the Chief Scientist awards discretionary grant to capsule endoscopy company to aid in technology development

Shorter procedure times, fewer wound complications, reduced post-surgical care cost. All hot buttons for medtech investors, so it seems

New money should keep foot on accelerator with commercialisation efforts of new spinal technologies

Proving the lure of an innovative, FDA approved technology

XENiOS® receives cash infusion from existing investors to expand commercial operations in US and Europe

There’s a high degree of continuity built into St. Jude’s succession plan, Michael Rousseau having been around since 1999 and COO since last year

New financing will accelerate R&D and accelerate global sales and marketing capabilities

It looks like ReWalk is enduring that tricky period for any nascent device company, where sales grow, but expenses grow more